POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions: Extrapulmonary Tuberculosis; Tuberculosis, Pulmonary; Human Immunodeficiency Virus (HIV); Acquired Immunodeficiency Syndrome Intervention: Diagnostic Test: LF-LAM Sponsors: University of Southern Denmark; Odense University Hospital; National Tuberculosis Control Programme, Ghana; Odense Patient Data Explorative Network; University of Ghana; Tema General Hospital, Ghana; Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials
ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions: Mycobacterium Tuberculosis, Protection Against; Tuberculosis Interventions: Biological: ChadOx1 85A - aerosol; Biological: ChadOx1 85A - IM Sponsors: François Spertini; University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials
POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions: Extrapulmonary Tuberculosis; Tuberculosis, Pulmonary; Human Immunodeficiency Virus (HIV); Acquired Immunodeficiency Syndrome Intervention: Diagnostic Test: LF-LAM Sponsors: University of Southern Denmark; Odense University Hospital; National Tuberculosis Control Programme, Ghana; Odense Patient Data Explorative Network; University of Ghana; Tema General Hospital, Ghana; Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials
ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions: Mycobacterium Tuberculosis, Protection Against; Tuberculosis Interventions: Biological: ChadOx1 85A - aerosol; Biological: ChadOx1 85A - IM Sponsors: François Spertini; University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials
POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions: Extrapulmonary Tuberculosis; Tuberculosis, Pulmonary; Human Immunodeficiency Virus (HIV); Acquired Immunodeficiency Syndrome Intervention: Diagnostic Test: LF-LAM Sponsors: University of Southern Denmark; Odense University Hospital; National Tuberculosis Control Programme, Ghana; Odense Patient Data Explorative Network; University of Ghana; Tema General Hospital, Ghana; Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials
ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions: Mycobacterium Tuberculosis, Protection Against; Tuberculosis Interventions: Biological: ChadOx1 85A - aerosol; Biological: ChadOx1 85A - IM Sponsors: François Spertini; University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials
POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions: Extrapulmonary Tuberculosis; Tuberculosis, Pulmonary; Human Immunodeficiency Virus (HIV); Acquired Immunodeficiency Syndrome Intervention: Diagnostic Test: LF-LAM Sponsors: University of Southern Denmark; Odense University Hospital; National Tuberculosis Control Programme, Ghana; Odense Patient Data Explorative Network; University of Ghana; Tema General Hospital, Ghana; Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials
Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions: HIV/AIDS; Tuberculosis Intervention: Drug: Dose escalation Sponsors: University of Liverpool; European and Developing Countries Clinical Trials Partnership (EDCTP); Joint Clinical Research Centre, Kampala, Uganda; University of Cape Town, Cape Town, South Africa; Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda; University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children
Conditions: Tuberculosis; HIV Intervention: Other: External validation of the PAANTHER TB treatment decision algorithm Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions: HIV/AIDS; Tuberculosis Intervention: Drug: Dose escalation Sponsors: University of Liverpool; European and Developing Countries Clinical Trials Partnership (EDCTP); Joint Clinical Research Centre, Kampala, Uganda; University of Cape Town, Cape Town, South Africa; Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda; University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children
Conditions: Tuberculosis; HIV Intervention: Other: External validation of the PAANTHER TB treatment decision algorithm Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions: HIV/AIDS; Tuberculosis Intervention: Drug: Dose escalation Sponsors: University of Liverpool; European and Developing Countries Clinical Trials Partnership (EDCTP); Joint Clinical Research Centre, Kampala, Uganda; University of Cape Town, Cape Town, South Africa; Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda; University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children
Conditions: Tuberculosis; HIV Intervention: Other: External validation of the PAANTHER TB treatment decision algorithm Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions: HIV/AIDS; Tuberculosis Intervention: Drug: Dose escalation Sponsors: University of Liverpool; European and Developing Countries Clinical Trials Partnership (EDCTP); Joint Clinical Research Centre, Kampala, Uganda; University of Cape Town, Cape Town, South Africa; Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda; University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children
Conditions: Tuberculosis; HIV Intervention: Other: External validation of the PAANTHER TB treatment decision algorithm Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions: HIV/AIDS; Tuberculosis Intervention: Drug: Dose escalation Sponsors: University of Liverpool; European and Developing Countries Clinical Trials Partnership (EDCTP); Joint Clinical Research Centre, Kampala, Uganda; University of Cape Town, Cape Town, South Africa; Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda; University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials
Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes
Conditions: Tuberculosis; Adherence, Patient; Adherence, Medication; Drug-resistant Tuberculosis Interventions: Behavioral: Keheala Mobile Health Platform and Behavioral Interventions; Behavioral: Social and Behavior Change Communication (SBCC); Behavioral: SMS Reminder; Other: Standard of Care Sponsors: Massachusetts Institute of Technology; Keheala; United States Agency for International Development (USAID); Kenya National Tuberculosis, Leprosy and Lung Disease Program; McGill&...
Source: ClinicalTrials.gov - October 8, 2019 Category: Research Source Type: clinical trials
Screening for Tuberculosis in Pregnancy
Condition: Latent Tuberculosis Intervention: Diagnostic Test: IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection Sponsors: Queen Mary University of London; University College, London; City, University of London; Imperial College London Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2019 Category: Research Source Type: clinical trials
Effect of Community Active Case Finding Strategies for Detection of Tuberculosis in Cambodia
Condition: Tuberculosis Interventions: Other: ACF with a seed-and-recruit model; Other: ACF targeting household and neighborhood contacts; Other: ACF targeting the older population using mobile screening units; Other: Passive case finding Sponsors: National University, Singapore; KHANA Center for Population Health Research; National Center for Tuberculosis and Leprosy Control; Cambodian Anti-Tuberculosis Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2019 Category: Research Source Type: clinical trials
FujiLAM Prospective Evaluation Trial
Condition: Diagnosis of Tuberculosis in People Living With HIV Intervention: Device: Fujifilm SILVAMP TB LAM Sponsors: Foundation for Innovative New Diagnostics, Switzerland; Centre for Infectious Disease Research in Zambia; Infectious Diseases Institute, Uganda; Malawi-Liverpool-Wellcome Trust Clinical Research Programme; Swiss TPH, Switzerland; Ifakara Health Institute, Tanzania; University of Cape Town; Viet Tiep Hospital, Vietnam; &...
Source: ClinicalTrials.gov - September 13, 2019 Category: Research Source Type: clinical trials
